돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 42245생성일: 2026년 10월 24일

Ammonia → N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-1H-benzimidazole-2-carboxamide

https://huagongshe.com/ko/reaction/42245

반응식

참여 물질

역할이름HCID투입량
반응물AmmoniaHCID 222—
반응물DiisopropylethylamineHCID 81531—
반응물2-Benzimidazolecarboxylic acidHCID 233240—
반응물6-(1H-Indol-4-yl)-2-(tetrahydro-2H-pyran-2-yl)-2H-indazol-4-amineHCID 58267995—
용매MethanolHCID 887—
용매DimethylformamideHCID 6228—
생성물N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-1H-benzimidazole-2-carboxamideHCID 44540221—

반응 단계

1H-Benzimidazole-2-carboxylic acid (available from Apollo Scientific, 25 mg, 0.151 mmol), O-(7-Azabenzatriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (63 mg, 0.17 mmol) and 6-(1H-indol-4-yl)-2-(tetrahydro-2H-pyran-2-yl)-2H-indazol-4-amine (50 mg, 0.15 mmol) were dissolved in anhydrous DMF (3 ml) and then treated with DIPEA (0.05 ml, 0.30 mmol). The reactions were then stirred at room temperature for 15 hours. The mixture was treated with methanol (3 ml) and then Macroporous-Tosic Acid (170 mg, 0.75 mmol) then stirred for 15 hours. The mixture was then treated with 0.88 ammonia solution (0.60 ml), stirred for 10 minutes, then filtered and solvent blown off under a stream of nitrogen. The crude residue was purified by Mass Directed Automated Preparative HPLC (Method B) to give after evaporation of solvents the title compound as a yellow solid (27 mg). LCMS (Method B) m/z 393 [MH+], Rt=1.04 min.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08536169B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-faf48123d94743ae808c61a29cfd745c
출처 메모uspto-grants-2013_09